- Home
- SIFY vs FULC Comparison
SIFY vs FULC Comparison
Compare SIFY & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIFY
- FULC
- Stock Information
- Founded
- SIFY 1995
- FULC 2015
- Country
- SIFY India
- FULC United States
- Employees
- SIFY N/A
- FULC N/A
- Industry
- SIFY Computer Software: Programming Data Processing
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- SIFY Technology
- FULC Health Care
- Exchange
- SIFY Nasdaq
- FULC Nasdaq
- Market Cap
- SIFY 218.1M
- FULC 221.5M
- IPO Year
- SIFY 1999
- FULC 2019
- Fundamental
- Price
- SIFY $2.89
- FULC $3.96
- Analyst Decision
- SIFY
- FULC Hold
- Analyst Count
- SIFY 0
- FULC 10
- Target Price
- SIFY N/A
- FULC $7.44
- AVG Volume (30 Days)
- SIFY 77.5K
- FULC 1.0M
- Earning Date
- SIFY 01-17-2025
- FULC 02-25-2025
- Dividend Yield
- SIFY N/A
- FULC N/A
- EPS Growth
- SIFY N/A
- FULC N/A
- EPS
- SIFY N/A
- FULC N/A
- Revenue
- SIFY $465,333,571.00
- FULC $80,871,000.00
- Revenue This Year
- SIFY N/A
- FULC $2,821.96
- Revenue Next Year
- SIFY $12.52
- FULC N/A
- P/E Ratio
- SIFY N/A
- FULC N/A
- Revenue Growth
- SIFY 14.34
- FULC 2987.86
- 52 Week Low
- SIFY $1.80
- FULC $2.86
- 52 Week High
- SIFY $10.14
- FULC $13.70
- Technical
- Relative Strength Index (RSI)
- SIFY 44.10
- FULC 41.64
- Support Level
- SIFY $2.81
- FULC $3.93
- Resistance Level
- SIFY $3.29
- FULC $5.17
- Average True Range (ATR)
- SIFY 0.19
- FULC 0.30
- MACD
- SIFY 0.01
- FULC -0.13
- Stochastic Oscillator
- SIFY 16.67
- FULC 3.97
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.